Get started
Author

Cheng‐Yu Tsai

Observed names: C.‐Y. Tsai, Cheng-Yu Tsai, Tsai, Cheng-Yu
Observed institutions: The University of Texas MD Anderson Cancer Center, The University of Texas System, University of California San Diego, Stanford Medicine, Moores Cancer Center, Stanford Cardiovascular Institute, Stanford University
ORCID: 0000-0002-6351-1858
Observed ORCID: 0000-0002-6351-1858
OpenAlex ID: A5057196672
TRIM24 links a non-canonical histone signature to breast cancer
2010 · Wen-Wei Tsai, Zhanxin Wang, et al. · Nature · 458
PDF
Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling
2012 · Cheng-Yu Tsai, J. Cameron Finley, et al. · Biochemical Pharmacology · 91
APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells
2018 · Andrea Local, Hongying Zhang, et al. · Molecular Cancer Therapeutics · 85
PDF
Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity
2016 · Kristin M. Bompiani, Cheng-Yu Tsai, et al. · Metallomics · 68
The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2)
2015 · Cheng-Yu Tsai, Janika K. Liebig, et al. · Metallomics · 46
PDF
APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency
2018 · Cheng-Yu Tsai, Si Sun, et al. · Molecular Cancer Therapeutics · 24
PDF
Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4
2014 · Cheng-Yu Tsai, Christopher A. Larson, et al. · Biochemical Pharmacology · 24
The role of asparagine synthetase on nutrient metabolism in pancreatic disease
2020 · Cheng-Yu Tsai, Michael S. Kilberg, et al. · Pancreatology · 21
Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository
2021 · Toshie Saito, Yue Wei, et al. · Metabolomics · 20
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis
2023 · Cheng-Yu Tsai, Toshie Saito, et al. · Science Translational Medicine · 16
PDF
Targeting DNA Repair in Chronic Lymphocytic Leukemia Cells with a Novel Acyclic Nucleotide Analogue, GS-9219
2009 · Cheng-Yu Tsai, Adrian S. Ray, et al. · Clinical Cancer Research · 15
Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis?
2025 · Gayathri Swaminathan, Yu-Chu Lin, et al. · Pancreatology · 13
PDF
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
2022 · Alexander T. Wenzel, Devora Champa, et al. · npj Systems Biology and Applications · 10
PDF
Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety
2023 · Jianbo Ni, Asna Khalid, et al. · Pancreatology · 8
PDF
Characterization of a monoclonal antibody capable of reliably quantifying expression of Human Copper Transporter 1 (hCTR1)
2013 · Jacob F. Quail, Cheng-Yu Tsai, et al. · Journal of Trace Elements in Medicine and Biology · 6
Rectal administration of tacrolimus protects against post-ERCP pancreatitis in mice
2023 · Yu-Chu Lin, Jianbo Ni, et al. · Pancreatology · 5
PDF
Abstract 794: CG'806, a first-in-class pan-FLT3/pan-BTK inhibitor, targets multiple pathways to kill diverse subtypes of acute myeloid leukemia and B-cell malignancy in vitro
2018 · Hongying Zhang, Andrea Local, et al. · Cancer Research · 4
Vitamin A and association with asparaginase-associated pancreatitis in children with acute lymphocytic leukemia.
2022 · Cheng-Yu Tsai, Toshie Saito, et al. · Journal of Clinical Oncology · 2
APTO-253 Interaction with G-Quadruplex DNA Is Linked to Inhibition of c-Myc Expression, Induction of DNA Damage, and Generation of Synthetic Lethality in Cells with BRCA1/2 Impairment
2017 · Andrea Local, Hongying Zhang, et al. · Blood · 2
CG '806, a First-in-Class Non-Covalent Pan-FLT3/BTK Inhibitor, Exerts Superior Potency Against B-Cell Malignant Cells
2017 · Hongying Zhang, Andrea Local, et al. · Blood · 2
Pf203 Cg‐806, Preclinical in Vivo Efficacy and Safety Profile as a Pan‐flt3/pan‐btk Inhibitor
2019 · H. Zhang, K. Benbatoul, et al. · HemaSphere · 1
CG '806, a Highly Potent First-in-Class Pan-FLT3/BTK Inhibitor, Targets Multiple Clusters of Kinases Operative in Diverse Subtypes of Acute Myeloid Leukemia
2017 · Hongying Zhang, Andrea Local, et al. · Blood · 1
Induction of acute pancreatitis in adult zebrafish: A reproducible and quantifiable experimental model
2026 · Prince Allawadhi, Cheng-Yu Tsai, et al. · Pancreatology
A lipid-immune network signature defines susceptibility to asparaginase-associated pancreatitis
2026 · Cheng-Yu Tsai, Na Bo, et al. · JCI Insight
PDF
803: Multiomic Profiling of Lipidomic and Proteomic Associations in Patients Prior to Developing Asparaginaseassociated Pancreatitis Signals to Novel Disease Signatures
2025 · Cheng-Yu Tsai, Na Bo, et al. · Gastroenterology
Works count: 69
Citation count: 922
H-index: 12
I10-index: 13
Year
Topic
Type